Software Alternatives & Startups

Digraph.dev VS SignalPGx

Compare Digraph.dev VS SignalPGx and see what are their differences

Digraph.dev

AI marketing platform for brands.

No screenshot yet
Rating
0 reviews
Pricing
Freemium Free trial $99 / Monthly
SignalPGx

Global pharmacogenomics reporting and medication intelligence platform with physician-reviewed PGx reports, SignalAI interpretation, EHR integrations, living reanalysis, and enterprise-grade security.

Rating
0 reviews
Note: These products don't have any matching categories. If you think this is a mistake, please edit the details of one of the products and suggest appropriate categories.

Which is more popular?

Marketing popularity
100% vs 0%
alternatives listed
1 vs 2

Base details

Website, pricing, platforms and company facts side by side.

Digraph.dev
SignalPGx
Website digraph.dev signalpgx.com
Pricing
Freemium Free trial $99 / Monthly Official pricing
—
Platforms —
Cloud Web SaaS AWS HL7 FHIR REST API +4
Company Startup from the United States · 1 - 9 employees 100 - 249 employees · 2026
Listed in

About Digraph.dev and SignalPGx

In their own words, as submitted to SaaSHub.

Digraph.dev
SignalPGx

Digraph is an AI marketing platform for brands. It brings together AI research, market intelligence, website and campaign analysis, specialist AI workflows, and marketer-led guidance to help teams understand what shapes buyer decisions and what to do next. Teams can measure how AI systems...

Read more about Digraph.dev

SignalPGx is a global pharmacogenomics reporting and medication intelligence platform built for laboratories, hospital systems, provider networks, clinics, pharmacy partners, and healthcare enterprises. The platform helps healthcare organizations turn genotype data into clear, evidence-backed...

Read more about SignalPGx

Features and specs

What each product offers, as listed by its team.

Digraph.dev 5 features
SignalPGx 12 features
  • Developer-focused positioning
    The .dev domain and branding suggest a tool built for developers and technical teams, so its workflows are likely to fit engineering needs better than a generic product. I could not browse the site, so this is inferred from its positioning rather than confirmed.
  • Graph-based approach
    The name 'Digraph' (directed graph) suggests it models information as connected nodes and relationships. That kind of structure can make dependencies, ideas, or decisions easier to see than flat lists or documents. Confirm how the product actually uses this.
  • Modern, minimal presentation
    Newer developer tools tend to have lean interfaces and a focused feature set, which can mean a short learning curve and less clutter. I could not verify this for Digraph, so check it with a trial.
  • Potential for better organization and clarity
    If the tool works as the name suggests, visualizing relationships between items can improve shared understanding across a team. The benefit depends on how well the product is executed.
  • Early-stage responsiveness
    Smaller or newer products often respond quickly to user feedback and let users influence the roadmap. This is a general tendency and has not been verified for Digraph.
  • White-Label PGx Reports
    Branded pharmacogenomics reports delivered under your lab, hospital, or healthcare organization’s identity.
  • Physician-Reviewed Workflow
    Clinical review and sign-off workflow designed for physician-reviewed PGx report release.
  • SignalAI Interpretation
    AI-assisted, source-cited PGx interpretation support for medication guidance and clinical review.
  • Medication Intelligence Graph
    Evidence-driven gene-drug intelligence layer connecting PGx findings, medications, clinical evidence, and labeling.
  • Living Patient Passport
    Patient-accessible PGx profile that keeps medication guidance useful as medications, evidence, and guidelines change.
  • Living Reanalysis
    Re-evaluates PGx results when medications, evidence, or clinical guidance changes over time.
  • Medication Simulator
    Supports genotype-aware medication review, therapy comparison, and medication risk evaluation.
  • EHR Integration
    Supports SMART on FHIR, HL7/FHIR, CDS Hooks, and REST API connectivity.
  • Genotype File Support
    Supports VCF, Agena MassARRAY, CSV, and custom laboratory file formats. Feature name:
  • Enterprise Security
    Built with tenant isolation, RBAC, audit logging, encryption, and scalable multi-region AWS infrastructure.
  • Reimbursement Support
    Includes CPT, ICD-10, MolDX Z-code context, and audit-ready medical necessity documentation support.
  • Clinical Evidence Sources
    Uses trusted PGx and medication evidence sources including CPIC, DPWG, FDA labels, PharmGKB, RxNorm, and DailyMed.

Category popularity

How often each product is chosen within a category, 0–100% relative to the other.

Score bands 0–20 21–40 41–50 51–60 61–100
Digraph.dev
SignalPGx
100% 100%
0% 0%
0% 0%
100% 100%
100% 100%
0% 0%
0% 0%
100% 100%

Questions & Answers

As answered by people managing Digraph.dev and SignalPGx.

What makes your product unique?

SignalPGx's answer:

SignalPGx combines pharmacogenomics reporting, medication intelligence, physician-reviewed workflows, SignalAI-assisted interpretation, living reanalysis, and EHR-ready integrations in one platform.

Unlike static PGx report generators, SignalPGx is designed to keep medication guidance useful over time as medications, evidence, and clinical guidelines change. It supports white-label PGx reports, VCF, Agena MassARRAY, CSV, and custom file formats, plus integrations through SMART on FHIR, HL7/FHIR, CDS Hooks, and REST APIs.

SignalPGx also includes enterprise-grade security features such as tenant isolation, RBAC, audit logging, encryption, and scalable multi-region AWS infrastructure.

Why should a person choose your product over its competitors?

SignalPGx's answer:

SignalPGx is built for organizations that need more than a one-time PGx PDF. It helps labs, hospital systems, provider networks, clinics, and healthcare enterprises turn genotype data into evidence-backed medication guidance with clinical review, EHR integration, and long-term reanalysis.

Key advantages include white-label reporting, physician-reviewed workflows, SignalAI interpretation support, Medication Intelligence Graph, Living Patient Passport, medication simulation, reimbursement documentation support, and modern interoperability through SMART on FHIR, HL7/FHIR, CDS Hooks, and REST APIs.

It is designed for real clinical workflows, not just report generation.

Who are some of the biggest customers of your product?

SignalPGx's answer:

  • Customer names are not publicly disclosed at this time.
  • SignalPGx is designed for laboratories, hospital systems, provider networks, clinics, pharmacy partners, and healthcare enterprises.
  • Public customer or partner announcements will be shared through official SignalPGx channels when available.

How would you describe the primary audience of your product?

SignalPGx's answer:

SignalPGx is built for laboratories, hospital systems, health systems, provider networks, clinics, pharmacy partners, and healthcare enterprises that want to launch or expand pharmacogenomics reporting and medication intelligence workflows.

The platform is especially useful for organizations that need physician-reviewed PGx reports, branded reporting, EHR integration, medication guidance, evidence-backed interpretation, living reanalysis, and secure enterprise deployment.

What's the story behind your product?

SignalPGx's answer:

SignalPGx was created because pharmacogenomics deserves more than a static report. Many PGx workflows still depend on PDFs, manual interpretation, disconnected evidence sources, and limited EHR integration.

SignalPGx was built to turn genotype data into living medication intelligence. The platform brings together evidence-backed PGx reporting, physician-reviewed workflows, SignalAI-assisted interpretation, branded reports, EHR integrations, medication simulation, and long-term reanalysis so PGx results can remain useful after the first report is released.

The goal is simple: help healthcare organizations make PGx reporting clearer, faster, more connected, and more clinically useful.

Which are the primary technologies used for building your product?

SignalPGx's answer:

SignalPGx uses modern cloud, interoperability, security, and clinical data technologies to support enterprise PGx reporting and medication intelligence.

Primary technologies and standards include AWS cloud infrastructure, multi-region deployment architecture, tenant isolation, role-based access control, audit logging, encryption in transit and at rest, REST APIs, SMART on FHIR, HL7/FHIR, CDS Hooks, LOINC, HGNC, RxNorm, and structured PGx data processing.

The platform also supports VCF, Agena MassARRAY, CSV, and custom laboratory file formats, with SignalAI-assisted interpretation and evidence mapping across trusted PGx and medication sources.

User comments

Share your experience with using Digraph.dev and SignalPGx. For example, how are they different and which one is better?

Log in or Post with

Alternatives to Digraph.dev and SignalPGx

When comparing Digraph.dev and SignalPGx, you can also consider the following products.